<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Human Papilloma Virus-positive Squamous Cell Carcinoma of the Oropharynx Arising in Pemphigus Vulgaris.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Human Papilloma Virus-positive Squamous Cell Carcinoma of the Oropharynx Arising in Pemphigus Vulgaris." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5498/9137360/6ba36bfa0fe2/ActaDV-100-10-5735-g001.jpg"/> </div> <div class="text-side"> <h1>Human Papilloma Virus-positive Squamous Cell Carcinoma of the Oropharynx Arising in Pemphigus Vulgaris.</h1> <p>(A) Overview of the course of the disease under therapy with presentation of anti-desmoglein-3 antibody ELISA (RE/ml), the pemphigus antibody titer (investigated by indirect immunofluorescence on monkey oesophagus; reciprocally displayed (e.g. titer 1:10 corresponds to diagram 10) and the PDAI score (active lesions); (B) Multiple erosions in the pharynx, soft and hard palate at the time of initial diagnosis of the poorly differentiated squamous cell carcinoma (SCC) of the oropharynx; (C) Histology of skin biopsy of the SCC: squamous epithelium with papillary proliferation with high-grade intraepithelial neoplasia/dysplasia (HE staining Ã— 10); (D) significant reduction of enoral erosions 8 months after primary radiotherapy.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32250440/" target="_blank">32250440</a></p><p>Type: Premalignant/Malignant, Category: Keratinocytic</p>
</div> </div></div></body></html>